141 related articles for article (PubMed ID: 19546757)
21. Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
Caritis SN; Rouse DJ; Peaceman AM; Sciscione A; Momirova V; Spong CY; Iams JD; Wapner RJ; Varner M; Carpenter M; Lo J; Thorp J; Mercer BM; Sorokin Y; Harper M; Ramin S; Anderson G;
Obstet Gynecol; 2009 Feb; 113(2 Pt 1):285-92. PubMed ID: 19155896
[TBL] [Abstract][Full Text] [Related]
22. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.
Romero R; Stanczyk FZ
Am J Obstet Gynecol; 2013 Jun; 208(6):421-6. PubMed ID: 23643669
[No Abstract] [Full Text] [Related]
23. Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.
Rebarber A; Istwan NB; Russo-Stieglitz K; Cleary-Goldman J; Rhea DJ; Stanziano GJ; Saltzman DH
Diabetes Care; 2007 Sep; 30(9):2277-80. PubMed ID: 17563346
[TBL] [Abstract][Full Text] [Related]
24. Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation.
Caritis SN; Simhan HN; Zhao Y; Rouse DJ; Peaceman AM; Sciscione A; Spong CY; Varner MW; Malone FD; Iams JD; Mercer BM; Thorp JM; Sorokin Y; Carpenter M; Lo J; Ramin SM; Harper M;
Am J Obstet Gynecol; 2012 Nov; 207(5):396.e1-8. PubMed ID: 22959763
[TBL] [Abstract][Full Text] [Related]
25. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
O'Brien JM; Lewis DF
Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
[TBL] [Abstract][Full Text] [Related]
26. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.
Resseguie LJ; Hick JF; Bruen JA; Noller KL; O'Fallon WM; Kurland LT
Fertil Steril; 1985 Apr; 43(4):514-9. PubMed ID: 3987922
[TBL] [Abstract][Full Text] [Related]
27. Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial.
Facchinetti F; Vergani P; Di Tommaso M; Marozio L; Acaia B; Vicini R; Pignatti L; Locatelli A; Spitaleri M; Benedetto C; Zaina B; DʼAmico R
Obstet Gynecol; 2017 Jul; 130(1):64-70. PubMed ID: 28594783
[TBL] [Abstract][Full Text] [Related]
28. Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth.
Rouholamin S; Zarean E; Sadeghi L
Adv Biomed Res; 2015; 4():242. PubMed ID: 26682208
[TBL] [Abstract][Full Text] [Related]
29. Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and metaanalysis of randomized controlled trials.
Quist-Nelson J; Parker P; Mokhtari N; Di Sarno R; Saccone G; Berghella V
Am J Obstet Gynecol; 2018 Oct; 219(4):346-355.e2. PubMed ID: 29614278
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
Saghafi N; Khadem N; Mohajeri T; Shakeri MT
J Obstet Gynaecol Res; 2011 Oct; 37(10):1342-5. PubMed ID: 21564406
[TBL] [Abstract][Full Text] [Related]
31. Perinatal outcomes in Hispanic and non-Hispanic white women with mild gestational diabetes.
Berggren EK; Mele L; Landon MB; Spong CY; Ramin SM; Casey B; Wapner RJ; Varner MW; Rouse DJ; Sciscione A; Catalano P; Harper M; Saade G; Caritis SN; Sorokin Y; Peaceman AM; Tolosa JE;
Obstet Gynecol; 2012 Nov; 120(5):1099-104. PubMed ID: 23090528
[TBL] [Abstract][Full Text] [Related]
32. Effects of progestogens in women with preterm premature rupture of membranes.
Di Sarno R; Raffone A; Saccone G
Minerva Ginecol; 2019 Apr; 71(2):121-124. PubMed ID: 30318880
[TBL] [Abstract][Full Text] [Related]
33. Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps.
Owens L; Prager S
Obstet Gynecol; 2017 May; 129(5):945. PubMed ID: 28426603
[No Abstract] [Full Text] [Related]
34. Effect of weekly 17-hydroxyprogesterone caproate on small for gestational age among pregnant women with HIV in Zambia.
Conner MG; Vwalika B; Freeman BL; Sebastião YV; Mabula-Bwalya CM; Cole SR; Stringer EM; Kasaro MP; Stringer JSA; Price JT
AIDS; 2022 Nov; 36(14):2079-2081. PubMed ID: 36305188
[TBL] [Abstract][Full Text] [Related]
35. Iatrogenic autoimmune progesterone dermatitis caused by 17alpha-hydroxyprogesterone caproate for preterm labor prevention.
Bandino JP; Thoppil J; Kennedy JS; Hivnor CM
Cutis; 2011 Nov; 88(5):241-3. PubMed ID: 22272488
[TBL] [Abstract][Full Text] [Related]
36. The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes.
Mayo K; Melamed N; Vandenberghe H; Berger H
Am J Obstet Gynecol; 2015 Feb; 212(2):224.e1-9. PubMed ID: 25173183
[TBL] [Abstract][Full Text] [Related]
37. Rates of recurrent preterm birth by maternal body habitus in women receiving 17α-hydroxyprogesterone caproate.
Timofeev J; Feghali M; Boyle A; Istwan N; Rhea D; Driggers RW
J Matern Fetal Neonatal Med; 2013 Jun; 26(9):881-4. PubMed ID: 23311766
[TBL] [Abstract][Full Text] [Related]
38. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group.
Joffe GM; Esterlitz JR; Levine RJ; Clemens JD; Ewell MG; Sibai BM; Catalano PM
Am J Obstet Gynecol; 1998 Oct; 179(4):1032-7. PubMed ID: 9790393
[TBL] [Abstract][Full Text] [Related]
39. Relation of body mass index to frequency of recurrent preterm birth in women treated with 17-alpha hydroxyprogesterone caproate.
Co AL; Walker HC; Hade EM; Iams JD
Am J Obstet Gynecol; 2015 Aug; 213(2):233.e1-5. PubMed ID: 25912300
[TBL] [Abstract][Full Text] [Related]
40. Prevention of Preterm Labor with 17α-Hydroxyprogesterone (17OHP) Caproate: A Comparison of Adverse Drug Reaction Rates between Compounded and Commercial Formulations.
Stone RH; Bobowski C; Milikhiker N; Anguiano RH; Mastrogiannis D
Am J Perinatol; 2017 Dec; 34(14):1436-1441. PubMed ID: 28704849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
